𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neural Cell Adhesion Molecule Expression in Adenoid Cystic Carcinoma of the Head and Neck

✍ Scribed by James A. Hutcheson; Emre Vural; Sohelia Korourian; Ehab Hanna

Book ID
110082317
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
397 KB
Volume
110
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neural cell adhesion molecule expression
Neural cell adhesion molecule expression: No correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck
✍ C. Arturo Solares; Ian Brown; Glen M. Boyle; Peter G. Parsons; Benedict Panizza πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 238 KB πŸ‘ 1 views

## Abstract ## __Background.__ Perineural invasion (PNI) in cutaneous squamous cell carcinoma of the head and neck (CSCCHN) is associated with decreased survival, particularly in patients with clinical signs of cranial nerve involvement. There is evidence to indicate that neural cell adhesion mole

Aberrant cytokine expression in serum of
Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck
✍ Thomas K. Hoffmann; Eniko Sonkoly; Bernhard Homey; Katrin Scheckenbach; Christia πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 2 views

## Abstract ## Background. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) represent 2 clinically important subtypes of head and neck cancer. Our objective was to characterize and compare cytokine profiles in the systemic circulation of patients with SCC and ACC. ## Methods. Mul

Cisplatin-based chemotherapy in advanced
Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck
✍ L. De Dick Haan; Dr. Pieter H. M. De Mulder; Dr. Jan B. Vermorken; Dr. Jan H. Sc πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 488 KB πŸ‘ 2 views

Nineteen patients, nine men and 10 women, with advanced adenoid cystic carcinoma (ACC), were treated with cisplatin either alone or in combination with doxorubicin and bleomycin. Median age was 51 years (range: 32-73 years). Two groups of patients were distinguished: Group 1 (N = 10) received single